Agminated benign vascular tumour successfully treated with trametinib-Reference-Cited by-同舟云学术

Agminated benign vascular tumour successfully treated with trametinib

Published:2021-03-08 Issue:6 Volume:184 Page:1195-1197
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Greenberger S.¹²^ORCID,Stein R.²³,Ollech A.¹²,Hartstein M.E.²³,Benyamini O.³,Yalon M.²⁴,Levi A.²⁵,Lapidoth M.²⁵,Barzilai A.²⁶

Affiliation:

1. Pediatric Dermatology Service Department of Dermatology Sheba Medical Center Ramat‐Gan Israel

2. Sackler Faculty of Medicine Tel Aviv University Tel Aviv69978Israel

3. Division of Ophthalmic Plastic and Reconstructive Surgery Department of Ophthalmology and Visual Sciences Yitzhak Shamir Medical CenterTel Aviv University Tzrifin Israel

4. Pediatric Neuro‐Oncology Service Pediatric Hemato‐Oncology Department Chaim Sheba Medical Center Tel HaShomer52621Israel

5. Department of DermatologyLaser UnitRabin Medical Center Petach Tikva Israel

6. Department of Dermatology Sheba Medical Center Ramat‐Gan Israel

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19814

Reference8 articles.

1. Theranostic Advances in Vascular Malformations

2. Hemangiomas, Angiosarcomas, and Vascular Malformations Represent the Signaling Abnormalities of Pathogenic Angiogenesis

3. Somatic Activating RAS Mutations Cause Vascular Tumors Including Pyogenic Granuloma

4. BRAF and RAS Mutations in Sporadic and Secondary Pyogenic Granuloma

5. PYOGENIC GRANULOMA RECUKRING WITH MULTIPLE SATELLITES.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition;Pediatric Research;2022-03-04